Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01304706 · ClinicalTrials.gov registry record · Phase 3
Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study
A Phase 3 study, sponsored by Alimera Sciences.
- Completed
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
NCT01304706 is a Phase 3 study that has completed, run by Alimera Sciences. The registered enrollment target is 120 participants.
The verdict
NCT01304706, a Phase 3 study, has completed, sponsored by Alimera Sciences.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
Study Summary
This study will assess the safety and utility of the new inserter for the administration of ILUVIEN in subjects with diabetic macular edema.
Interventions
- DRUG Fluocinolone Acetonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2011-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01304706
The ClinicalTrials.gov registry entry for NCT01304706 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alimera Sciences, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fluocinolone Acetonide is the first listed.
NCT01304706 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01304706 about?
NCT01304706 is a clinical study titled "Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study". This study will assess the safety and utility of the new inserter for the administration of ILUVIEN in subjects with diabetic macular edema.
What is the current status of trial NCT01304706?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2011-04.
What interventions are being tested in trial NCT01304706?
The interventions under investigation include: Fluocinolone Acetonide (DRUG).
Who is sponsoring clinical trial NCT01304706?
This trial is sponsored by Alimera Sciences, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.